CAS 836620-48-5
:3-Quinolinecarboxylic acid,5-amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-
Description:
3-Quinolinecarboxylic acid, 5-amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-1,4-dihydro-4-oxo- is a complex organic compound characterized by its quinoline structure, which is a bicyclic aromatic compound containing a nitrogen atom. This substance features a carboxylic acid functional group, an amino group, and a cyclohexylamino substituent, contributing to its potential biological activity. The presence of a fluorine atom enhances its lipophilicity and may influence its pharmacological properties. The dihydro-4-oxo moiety indicates that it has a ketone functional group, which can participate in various chemical reactions. This compound may exhibit interesting properties such as antimicrobial or antitumor activity, making it of interest in medicinal chemistry. Its structural complexity suggests that it could interact with biological targets, potentially leading to therapeutic applications. As with many organic compounds, its solubility, stability, and reactivity will depend on the specific conditions and environment in which it is studied.
Formula:C18H22FN3O3
Synonyms:- CS-2538
- 5-Amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- 5-Amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
- AS1842856
- AS 1842856;AS-1842856
- 3-Quinolinecarboxylic acid, 5-amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
Ref: IN-DA00G7DH
1mg70.00€5mg129.00€10mg158.00€25mg276.00€50mg521.00€100mg552.00€250mgTo inquire500mgTo inquireAS1842856
CAS:<p>AS1842856 is a Foxo1 inhibitor that blocks the transcriptional activity of Foxo1. AS1842856 has autophagy inhibitory activity. Cost-effective and quality-assured.</p>Formula:C18H22FN3O3Purity:99.36% - >99.99%Color and Shape:SolidMolecular weight:347.38AS1842856
CAS:<p>AS1842856 is a cell factor that belongs to the group of transcriptional regulators and is found in human serum. AS1842856 regulates the expression of FOXO1, which is involved in autophagy, metabolism and cell cycle regulation. AS1842856 has been shown to induce autophagy by activating the expression of ATG5 and ATG7. The chemical inhibitors of this drug have been shown to inhibit mitochondrial membrane potential and reduce ATP levels in human hepatocyte-like cells. These findings are consistent with its ability to induce autophagy through the induction of FOXO1.</p>Formula:C18H22FN3O3Purity:Min. 95%Molecular weight:347.38 g/mol



